Article
Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma
21 Feb 2019
Abstract excerpt
BACKGROUND: To improve cure rates for neuroblastoma (NB), it is important and necessary to evaluate therapy response. Our investigation focuses on using plasma cell free DNA (cfDNA) as a biomarker to determine tumor burden and minimal residual disease (MRD) of NB patients during chemotherapy. METHODS: Total 58 NB patients were recruited from July 2016 to December 2017. Therapy regime and risk classification were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
